Mark A. Russell

4.8k total citations
76 papers, 2.9k citations indexed

About

Mark A. Russell is a scholar working on Genetics, Surgery and Organic Chemistry. According to data from OpenAlex, Mark A. Russell has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 22 papers in Surgery and 14 papers in Organic Chemistry. Recurrent topics in Mark A. Russell's work include Diabetes and associated disorders (21 papers), Pancreatic function and diabetes (19 papers) and Immune Cell Function and Interaction (8 papers). Mark A. Russell is often cited by papers focused on Diabetes and associated disorders (21 papers), Pancreatic function and diabetes (19 papers) and Immune Cell Function and Interaction (8 papers). Mark A. Russell collaborates with scholars based in United Kingdom, United States and Norway. Mark A. Russell's co-authors include Desmond E. Walling, R. A. Hodgkinson, Noel G. Morgan, J. M. Phillips, Sarah J. Richardson, R.L. Parfitt, Rhys Parfitt, Benny K.G. Theng, G. Jock Churchman and Anthony G. M. Barrett and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark A. Russell

75 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Russell United Kingdom 27 748 626 598 591 548 76 2.9k
Timothy J. Sullivan United States 29 219 0.3× 525 0.8× 196 0.3× 75 0.1× 439 0.8× 119 3.4k
François Petit France 29 792 1.1× 951 1.5× 346 0.6× 267 0.5× 413 0.8× 191 2.7k
Thomas Pütz Germany 35 350 0.5× 169 0.3× 299 0.5× 48 0.1× 560 1.0× 106 3.5k
Caitlin Hicks Pries United States 26 1.5k 2.0× 1.2k 1.8× 88 0.1× 182 0.3× 34 0.1× 63 4.0k
Robert Young United States 33 399 0.5× 336 0.5× 284 0.5× 741 1.3× 214 0.4× 96 2.9k
Jian Yang China 36 74 0.1× 1.1k 1.7× 237 0.4× 695 1.2× 64 0.1× 177 4.8k
Huiying Liu China 33 643 0.9× 951 1.5× 122 0.2× 103 0.2× 63 0.1× 100 3.6k
Jianing Wang China 35 98 0.1× 525 0.8× 99 0.2× 321 0.5× 67 0.1× 143 3.6k
Chunsheng Liu China 48 81 0.1× 279 0.4× 574 1.0× 71 0.1× 272 0.5× 195 6.8k
Andrew Brenner United States 39 165 0.2× 136 0.2× 357 0.6× 176 0.3× 149 0.3× 194 5.1k

Countries citing papers authored by Mark A. Russell

Since Specialization
Citations

This map shows the geographic impact of Mark A. Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Russell more than expected).

Fields of papers citing papers by Mark A. Russell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Russell. The network helps show where Mark A. Russell may publish in the future.

Co-authorship network of co-authors of Mark A. Russell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Russell. A scholar is included among the top collaborators of Mark A. Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Russell. Mark A. Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez-Hernandez, Javier, Mark A. Russell, Shalinee Dhayal, et al.. (2025). Soluble HLA Class I Is Released From Human β-Cells Following Exposure to Interferons. Diabetes. 74(6). 956–968. 1 indexed citations
2.
Russell, Mark A., et al.. (2023). B-Lymphoblastic Leukemia/Lymphoma. 6(1). 39–49. 1 indexed citations
3.
Russell, Mark A., Sarah J. Richardson, & Noel G. Morgan. (2023). The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. Frontiers in Endocrinology. 14. 1270325–1270325. 16 indexed citations
4.
Krogvold, Lars, Pia Leete, Mark A. Russell, et al.. (2022). Detection of Antiviral Tissue Responses and Increased Cell Stress in the Pancreatic Islets of Newly Diagnosed Type 1 Diabetes Patients: Results From the DiViD Study. Frontiers in Endocrinology. 13. 881997–881997. 11 indexed citations
5.
Russell, Mark A., et al.. (2020). Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based Chemotherapy. SHILAP Revista de lepidopterología. 2020. 1–5. 8 indexed citations
6.
Houssen, Maha E., Ania Manson, Lorena Lorenzo, et al.. (2019). Evidence that a STAT3 Mutation Causing Hyper IgE Syndrome Leads to Repression of Transcriptional Activity. SHILAP Revista de lepidopterología. 2019. 1–5. 1 indexed citations
7.
Wyatt, Rebecca C., Giacomo Lanzoni, Mark A. Russell, Ivan Gerling, & Sarah J. Richardson. (2019). What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes. Current Diabetes Reports. 19(12). 159–159. 36 indexed citations
8.
9.
Holm, Laurits J., Lars Krogvold, Jane P. Hasselby, et al.. (2018). Abnormal islet sphingolipid metabolism in type 1 diabetes. Diabetologia. 61(7). 1650–1661. 57 indexed citations
10.
Russell, Mark A., Manuela Pigors, Maha E. Houssen, et al.. (2017). A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID). Clinical Immunology. 187. 132–136. 21 indexed citations
11.
Taniguchi, Kazuto, Mark A. Russell, Sarah J. Richardson, & Noel G. Morgan. (2015). The subcellular distribution of cyclin-D1 and cyclin-D3 within human islet cells varies according to the status of the pancreas donor. Diabetologia. 58(9). 2056–2063. 3 indexed citations
12.
Richardson, Sarah J., Pia Leete, Shalinee Dhayal, et al.. (2013). Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 57(2). 392–401. 30 indexed citations
13.
Morgan, Noel G., Eleftheria Diakogiannaki, & Mark A. Russell. (2009). The Incubation and Monitoring of Cell Viability in Primary Rat Islets of Langerhans and Pancreatic β-Cell Lines. Methods in molecular biology. 560. 53–64. 3 indexed citations
14.
Russell, Mark A., Andrew P. Laws, John H. Atherton, & Michael I. Page. (2008). The mechanism of the phosphoramidite synthesis of polynucleotides. Organic & Biomolecular Chemistry. 6(18). 3270–3270. 17 indexed citations
15.
Russell, Mark A.. (2007). Between Tradition and Modernity. Berghahn Books.
16.
Russell, Mark A.. (2007). BETWEEN TRADITION AND MODERNITY. Berghahn Books. 2 indexed citations
17.
Russell, Mark A., Desmond E. Walling, & R. A. Hodgkinson. (2000). Appraisal of a simple sampling device for collecting time-integrated fluvial suspended sediment samples. IAHS-AISH publication. 119–127. 43 indexed citations
18.
19.
Parfitt, R. L., et al.. (1982). Response of ryegrass and white clover to phosphorus on an allophanic soil, Egmont black loam. New Zealand Journal of Agricultural Research. 25(4). 549–555. 14 indexed citations
20.
Russell, Mark A., et al.. (1981). Estimation of the amounts of allophane and other materials in the clay fraction of an Egmont loam profile and other volcanic ash soils, New Zealand. Australian Journal of Soil Research. 19(3). 185–195. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy J. Sullivan Breakdown of academic impact, for papers by François Petit Breakdown of academic impact, for papers by Thomas Pütz Breakdown of academic impact, for papers by Caitlin Hicks Pries Breakdown of academic impact, for papers by Robert Young Breakdown of academic impact, for papers by Jian Yang Breakdown of academic impact, for papers by Huiying Liu Breakdown of academic impact, for papers by Jianing Wang Breakdown of academic impact, for papers by Chunsheng Liu Breakdown of academic impact, for papers by Andrew Brenner
Rankless by CCL
2026